From: Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis
 | eGFR > 45 | eGFR ≤45 | p value |
---|---|---|---|
n | 42 | 14 | Â |
Asymptomatic | 15 (35.7%) | 2 (14.3%) | 0.11 |
Cough | 12 (28.6%) | 6 (42.9%) | 0.32 |
Sputum | 6 (14.3%) | 4 (28.6%) | 0.24 |
Chest pain | 4 (9.5%) | 1 (7.1%) | 0.78 |
Fever (>  37.5 °C) | 8 (19.0%) | 8 (57.1%) | < 0.01 |
Dyspnea | 2 (4.8%) | 1 (7.1%) | 0.74 |
Laboratory data | |||
 WBC (/mL)a | 6150 ± 5100 | 8550 ± 7575 | 0.01 |
 Lymphocyte cell (/mL)a | 1151.6 ± 740.4 | 1326.9 ± 518.0 | 0.87 |
 Serum albumin (g/dL)a | 3.8 ± 3.4 | 3.0 ± 2.6 | < 0.01 |
 Serum calciuma b | 9.6 ± 9.0 | 9.3 ± 9.1 | 0.88 |
 Immunoglobulin G (mg/dL)a | 903.5 ± 745.3 | 1233.5 ± 621.5 | 0.48 |
 CRP (mg/dL)a | 0.2 ± 0.1 | 2.1 ± 0.2 | 0.02 |
 Anti-cryptococcus antigena | 16 ± 1 | 8 ± 5 | 0.48 |